Hillhurst Bio Doses First Patient in Phase 2a Trial of HBI-002 for Parkinson’s Disease

Hillhurst Biopharmaceuticals Inc. ("Hillhurst Bio"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products bas...

June 17, 2026 | Wednesday | News
Lonza and Antharis Therapeutics Partner to Develop Next-Generation Dual-Payload ADCs for GI Cancers

Target-specific licensing agreement enabling Antharis to advance proprietary dual-payload antibody-drug conjugate (ADC) progra...

June 17, 2026 | Wednesday | News
VIVEbiotech Reaches Milestone with 15th In Vivo Lentiviral Vector Program, Reinforcing Leadership in Gene Therapy Manufacturing

VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO),  underscored its industry leadership in the dev...

June 17, 2026 | Wednesday | News
ZoBio Launches Integrated DNA-Encoded Library Hit Discovery Service to Accelerate Drug Discovery Against Challenging Targets

ZoBio, a boutique problem-solving Contract Research Organization (CRO) specializing in early gene-to-lead discovery, today announced the launch of its co...

June 17, 2026 | Wednesday | News
Quintara Biosciences Relocates Boston-Area Laboratory to Watertown to Expand Sequencing Capacity

As a strategic step to better support growing demand and strengthen future service capacity, Quintara Biosciences announced that its Boston area laboratory...

June 15, 2026 | Monday | News
Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy in Pancreatic Cancer Trial

Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, announc...

June 12, 2026 | Friday | News
T-CURX Secures First Clinical Trial Approval for TCX-001, Advancing Novel Non-Viral CAR-T Therapy into the Clinic

Clinical Trial approval for TCX-001 is another significant development milestone for T-CURX and marks the transition of T-CURX from a pre-clinical to a...

June 12, 2026 | Friday | News
Lung Cancer Research Foundation and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment and Patient Advocacy

The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca,  announced that two research awards focused on improving outcomes for...

June 11, 2026 | Thursday | News
AcCELLerated Biologics Partners with Forever Labs to Expand Access to Stem Cell Banking and Personalized Regenerative Therapies

Leading regenerative medicine innovators unite to deliver seamless stem cell banking and personalized biologic solutions for physicians and patients nati...

June 11, 2026 | Thursday | News
Idorsia Secures CHF 250 Million Financing Facility to Strengthen Balance Sheet and Extend Cash Runway

Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing...

June 10, 2026 | Wednesday | News
Phenomenex Launches Luna Omega HILIC LC Columns to Advance High-Performance Separation of Polar Compounds

Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, announced th...

June 10, 2026 | Wednesday | News
From Downtime to Digital Resilience: How Pharma Manufacturers Are Rethinking Spare Parts Strategy

As pharmaceutical manufacturers face increasing pressure to maintain production continuity, ensure regulatory compliance, and manage ageing equipment, the ...

June 10, 2026 | Wednesday | News
Real-World Evidence Highlights New Opportunities in Precision Prostate Cancer Care

The promise of precision oncology depends not only on scientific innovation but also on successful implementation in routine clinical practice. Drawing on ...

June 09, 2026 | Tuesday | Expert Opinion
Made Scientific and Pluristyx Partner to Streamline iPSC Therapy Development and Manufacturing

Strategic partnership integrates Pluristyx's clinical-grade iPSC platform into Made Scientific's CDMO services, giving developers a single-source path fr...

June 09, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close